Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1444192 · FYE Mar 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.08Day −7.56%Mkt cap $34M1Y −30.2%Off 52W high −59.8%Vol (1Y) 72.0%
Daily closing price, split-adjusted to the current basis; 1.7y shown of 435 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest10.0% of sh out |
| Days to cover9.2d |
| 13F net flow (QoQ)+1.01% |
| Top-10 13F concentration91.8% |
| Next report (est.)2026-09-19 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$7.8M |
| ROE−11.9% |
| ROIC−19.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−39.9% |
| 1Y−30.2% |
| Since incept. (ann.)−22.0% |
Total return through 2026-07-29 · series begins 2024-10-28. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)72.0% |
| Ann. volatility (3Y)71.9% |
| Sharpe (1Y)−0.10 |
| Sharpe (3Y)0.05 |
| Max drawdown (1Y)−59.5% |
| Max drawdown (3Y)−60.0% |
| Beta (3Y vs SPY)−0.88 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Cerity Partners LLC | 849,055 | $4M | 5.22% | +100.8% |
| Eversept Partners, LP | 756,600 | $4M | 4.65% | new |
| Nantahala Capital Management, LLC | 728,203 | $3M | 4.47% | −38.2% |
| BANK OF AMERICA CORP /DE/ | 494,723 | $2M | 3.04% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 401,656 | $2M | 2.47% | new |
| RENAISSANCE TECHNOLOGIES LLC | 243,910 | $1M | 1.50% | +87.9% |
| JANE STREET GROUP, LLC | 167,097 | $773,659 | 1.03% | new |
| CITADEL ADVISORS LLC | 98,742 | $457,176 | 0.61% | +133.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2025-12-31 | 2026-02-12 | −$0.14 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$0.06 | — | — | — |
| 2025-06-30 | 2025-08-12 | −$0.21 | — | — | — |
| 2024-12-31 | 2025-02-13 | −$0.36 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-09-19 is ESTIMATED from filing cadence (median gap 93d) — not company-confirmed.
